Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for autism in young children with neurofibromatosis type 1
2012-005742-38Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in Autism Spectrum Disorder (ASD) and neurofibromatosis type 1 (NF1) comparing Simvastatin with Placebo (2 arms). Primary endpoint: Autism spectrum disorder phenotype improvement. Started Apr 2013; status: completed.
02
Drugs
simvastatin
03
Conditions
Autism Spectrum Disorder (ASD)neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on 2012-005742-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005742-38.